The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kingswood buys wealth manager; Helios capacity grows

Mon, 15th Nov 2021 19:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Kingswood Holdings Ltd - London-based wealth manager - Agrees to acquire Money Matters Ltd, a privately owned wealth management business, primarily offering its services in the North East of England, for total cash consideration of GBP3.4 million, paid over 2 years. Notes GBP1.7 million will be paid immediately, with further GBP1.7 million paid on achievement of performance targets. Money Maters North East business holds about GBP115 million assets under administration from about 600 clients. Kingswood's UK CEO David Lawrence says: "We remain committed to perpetuating our stated growth strategy within the UK and internationally. This is our second acquisition of 2021 and we continue to have a strong pipeline of high-quality UK opportunities under negotiation, six of which are in exclusive due diligence as we continue to grow our financial planning and investment management reach across the UK. We expect to be making more announcements over the coming weeks.''

----------

Schroder Real Estate Investment Trust Ltd - invests in UK commercial real estate, seeking income and capital growth from active management - Exchanges or completes 13 new lettings, renewals and reviews which will generate GBP300,000 per annum of rental income and increase contracted rental income by GBP185,000 per annum since September 20. Notes set to deliver 80,000 square foot of operationally net zero carbon industrial, storage and distribution space at Stanley Green Trading Estate after receipt of a resolution to grant planning permission.

----------

Helios Underwriting PLC - London-based investment vehicle, which acquires and consolidates underwriting capacity at Lloyd's - Notes December 31 expected capacity value to rise to GBP60.2 million from GBP30.8 million a year earlier. Expecting to acquire 29 LLVs during 2021 with capacity of GBP35.4 million, which was valued at 2021 capacity prices at GBP18.0 million. Chief Executive Nigel Hanbury says: "I am delighted that the value of the capacity portfolio will increase to GBP60 million with the revaluation of the existing portfolio adding 9.6p to the tangible net asset value per share - a 6.6% increase." Company adds: "Helios continued to manage the capacity portfolio discarding unwanted syndicates and taking positions on syndicates, in particular syndicate 510 and syndicate 2689, taking the total additional capacity acquired at auction to GBP23.8 million for consideration of GBP2.6 million."

----------

Thalassa Holdings Ltd - British Virgin Islands-based investment company in real estate, fintech and robotics - Subsidiary id4 delivers "client space solution" to Swiss-based asset manager Geneva Management Group. "The id4 client space solution, delivered using cloud-based technology, will enable GMG to onboard clients remotely and to review KYC profiles periodically," company says.

----------

Insig AI PLC - London-based machine learning and data science firm serving asset management industry, formerly known as Catena - Signs proof of concept exercise with unnamed European asset manager with assets under management of several billion euros. "In this initial proof-of-concept exercise on one of the client's larger funds, valued in excess of EUR1 billion, Insig AI has been tasked to use its machine learning data and expertise to analyse and categorise the client's portfolio," company says.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - US partner Eton Pharmaceuticals signs co-promotion deal for Alkindi Sprinkle with Tolmar Pharmaceuticals. As part of deal, Tolmar's 62-person sales force will promote Alkindi Sprinkle to their paediatric endocrinology targets alongside its own existing product. "Eton has indicated that it expects the co-promotion agreement to translate to significantly faster adoption of Alkindi Sprinkle and to accelerate the time to reach peak conversion of patients from existing therapy. The terms of Diurnal's licensing agreement with Eton are unaffected by Eton's agreement with Tolmar," Diurnal says.

----------

Panthera Resources PLC - gold exploration and development company with assets in West Africa and India - Settles agreements with Metal Mining India Private Ltd to buy its Indian joint venture partner for AUD1.8 million, just under GBP1 million. Issues 3.0 million shares and pays GBP500,000 to close deal. Notes ownership interest in the Bhukia and Taregaon projects in India via IGL has increased to 100%, giving Panthera a 95% interest, if prospecting licences are granted in the future.

----------

Mkango Resources Ltd - Vancouver-based explorer for rare earth elements - German subsidiary HyProMag Ltd creates new business HyProMag GmbH alongside Pforzheim University professor Carlo Burkhardt. HyProMag will own 80% of new business, while Burkhardt will take own remaining 20%. "Germany is a major producer and market for rare earth magnets in Europe, and the establishment of HyProMag GmbH provides a strong platform to grow the business in the region. Germany has no domestic sources of primary rare earths. Development of domestic sources of recycled rare earths via the patented HPMS is a significant opportunity to diversify and strengthen development of a more resilient rare earths supply chain in Europe," company explains.

----------

W Resources PLC- tungsten, tin and gold mining and exploring in Spain and Portugal - Raises GBP750,000 from placing 12.5 million shares at 6 pence each. "Following the award of the mining licence at the Régua tungsten mine in Portugal, the majority of the funds raised from the placing will be used to progress the mine development and to accelerate the environmental impact study report this quarter, as the team works towards first production in the second half of 2022," company says. Notes it will also use part of the funds at the La Parrilla mine in Spain to improve the laboratories, finished goods warehouse and spare parts warehouse. Enlarged share capital now 133.1 million.

----------

Bradda Head Lithium Ltd - Isle of Man-based exploration and mining services provider - Signs binding letter of intent for royalty agreement with Lithium Royalty Corp for 2% gross overriding royalty for sedimentary lithium claims in central Arizona. Value of agreement worth USD8 million. Notes USD2.5 million will be paid on closing of deal, USD2.5 million will be paid after Bradda obtains 1 million tonnes lithium carbonate equivalent; and finally, USD3 million to be paid after Bradda obtains 2.5 million tonnes lithium. Chief Executive Charles FitzRoy says: "We are delighted that Lithium Royalty Corporation has chosen to partner with us. This agreement further endorses the confidence in and inherent value that we believe our assets have; as well as in the future potential of the Company and our strategy given LRC's investment in Bradda."

----------

Chaarat Gold Holdings Ltd - gold miner in Armenia and mine developer in Kyrgyz Republic - Chief Financial Office Chris Eger to leave firm on November 30. Company says CFO will "pursue other opportunities". "Chris leaves with the board's appreciation and thanks for the role he has played in the development of Chaarat over the last three years," company adds. Starts search for replacement, and says current management team will assume Eger's responsibilities.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.